Bristol Myers Squibb has announced that the FDA has given approval to label updates for Breyanzi and Abecma to treat multiple ...

The collaboration, set to begin on 1 July, will see Novo Nordisk team up with the telehealth company to offer Wegovy to ...

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...

I’m in London, and I just paid for this damn fat drug I take. I said, it’s not working. They said, he said, I just paid $88 ...

Oligonucleotides could become a transformative treatment for a range of serious health conditions, but scaling up production is a persistent challenge. A new specialist manufacturing facility in ...

Equipped with a new CEO, Vor Bio is transitioning into an autoimmune player, leaving cell and gene therapy behind.

Theravance Biopharma’s partner Viatris has received China's NMPA approval for Yupelri inhalation solution for maintenance treatment of COPD.

While the UK continues its close 25-year partnership with Gavi, the US is halting funding to the organisation. In a move that ...

The CDE of China's NMPA has granted BioCity's endothelin receptor type A (ETA) antagonist, SC0062, a second BTD.

The US FDA has granted approval for a label update to Eli Lilly and Company's Amyvid (florbetapir F 18 injection) for use ...

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...

Kymera’s programme focuses on removing CDK2 from cells compared to other therapies that target the protein’s inhibition.